Engrossed
Underlined text would be added to current law. Struck-through text would be removed.
| By: Perry, West | S.B. No. 1868 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to adding certain substances to the Texas Controlled | |
| Substances Act and regulating kratom and kratom products; | |
| increasing civil penalties; creating criminal offenses; increasing | |
| a criminal penalty. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Chapter 444, Health and Safety Code, as added by | |
| Chapter 2 (S.B. 497), Acts of the 88th Legislature, Regular | |
| Session, 2023, is redesignated as Chapter 445, Health and Safety | |
| Code, and amended to read as follows: | |
| CHAPTER 445 [ |
|
| PRODUCTS | |
| Sec. 445.001 [ |
|
| (1) "Food" has the meaning assigned by Section | |
| 431.002. | |
| (2) "Kratom" means any part of the leaf of the plant of | |
| the species Mitragyna speciosa. | |
| (3) "Kratom processor" means a person who: | |
| (A) processes kratom for a kratom product; | |
| (B) manufactures, prepares, or distributes[ |
|
| (C) [ |
|
| oneself out as a manufacturer or[ |
|
| products; | |
| (D) [ |
|
| and proper labeling of kratom products; or | |
| (E) [ |
|
| (4) "Kratom product" means a food that contains[ |
|
| kratom. | |
| (5) "Kratom retailer" means a person [ |
|
| consumers or who advertises, represents, or holds oneself out as a | |
| person who sells kratom products to consumers. | |
| (6) "Manufacture" has the meaning assigned by Section | |
| 431.002. | |
| Sec. 445.002 [ |
|
| REQUIRED. (a) Before a kratom product is sold at retail or | |
| otherwise introduced into commerce in this state, a sample | |
| representing the kratom product must be tested: | |
| (1) by a laboratory that is: | |
| (A) located in this state; and | |
| (B) accredited by an accreditation body in | |
| accordance with International Organization for Standardization | |
| ISO/IEC 17025 or a comparable or successor standard; and | |
| (2) to determine: | |
| (A) the concentration and identity of the | |
| alkaloids in the product; and | |
| (B) the presence or quantity of heavy metals, | |
| pesticides, microbial contamination, and any other substances in | |
| the product as prescribed by the executive commissioner. | |
| (b) A kratom processor shall label each kratom product with | |
| the product use directions necessary to ensure safe use of the | |
| product by a consumer, including the recommended serving size for | |
| the product. | |
| (c) [ |
|
| that is properly tested and labeled in accordance with this | |
| section. | |
| (d) A person commits an offense if the person sells or | |
| offers for sale a kratom product or a product marketed as containing | |
| kratom that is not tested or labeled as required by this section. | |
| (e) An offense under this section is a Class A misdemeanor. | |
| Sec. 445.003 [ |
|
| PROHIBITED KRATOM PRODUCTS. (a) A person commits an offense if | |
| the person manufactures, prepares, distributes, sells, or offers | |
| for sale [ |
|
| (1) is adulterated with a dangerous non-kratom | |
| substance affecting the quality or strength of the product to a | |
| degree that renders the product injurious to a consumer; | |
| (2) is contaminated with a poisonous or otherwise | |
| deleterious non-kratom substance, including any substance | |
| designated as a controlled substance by Chapter 481 (Texas | |
| Controlled Substances Act); | |
| (3) contains a level of 7-hydroxymitragynine in the | |
| alkaloid fraction that is greater than 0.1 [ |
|
| overall alkaloid composition of the product; [ |
|
| (4) contains any artificial or synthetic alkaloids, | |
| including artificial or synthetic 7-hydroxymitragynine and | |
| synthetically derived compounds from [ |
|
| (5) is a prepackaged beverage; or | |
| (6) is a prepackaged food other than: | |
| (A) raw or dried kratom leaves; | |
| (B) ground kratom leaves; | |
| (C) kratom leaf powder; or | |
| (D) clear capsules containing kratom leaf powder | |
| [ |
|
| (b) An offense under this section is a Class A misdemeanor. | |
| (c) A kratom product described by Subsection (a) is | |
| considered to be adulterated for purposes of Chapter 431. | |
| Sec. 445.004 [ |
|
| SALE OF KRATOM PRODUCT TO INDIVIDUAL YOUNGER THAN 21 YEARS OF AGE | |
| [ |
|
| distributes, sells, or exposes for sale a kratom product or a | |
| product marketed as containing kratom to an individual younger than | |
| 21 [ |
|
| (b) An offense under this section is a Class A [ |
|
| misdemeanor. | |
| Sec. 445.005. OFFENSE: SALE OR DELIVERY OF CERTAIN KRATOM | |
| PRODUCTS NEAR SCHOOL. (a) In this section, "school" and | |
| "premises" have the meanings assigned by Section 481.134. | |
| (b) A person commits an offense if the person sells, offers | |
| for sale, or delivers a kratom product or a product marketed as | |
| containing kratom in, on, or within 1,000 feet of the premises of a | |
| school. | |
| (c) An offense under this section is a Class A misdemeanor. | |
| Sec. 445.006. OFFENSE: FALSE LABORATORY REPORT. (a) A | |
| person commits an offense if the person, with the intent to deceive, | |
| forges, falsifies, or alters the results of a laboratory test | |
| authorized or required by this chapter. | |
| (b) An offense under this section is a felony of the third | |
| degree. | |
| Sec. 445.007. OFFENSE: SALE OF OTHER PRODUCTS PROHIBITED. | |
| (a) A person commits an offense if the person sells or offers for | |
| sale a kratom product or a product marketed as containing kratom at | |
| a location that also sells or offers for sale the following products | |
| or products marketed as the following products: | |
| (1) a consumable hemp product as defined by Section | |
| 443.001; | |
| (2) a cigarette, e-cigarette, or tobacco product as | |
| defined by Section 161.081; or | |
| (3) an alcoholic beverage as defined by Section 1.04, | |
| Alcoholic Beverage Code. | |
| (b) An offense under this section is a Class A misdemeanor. | |
| Sec. 445.0071. OFFENSE: MANUFACTURE, DISTRIBUTION, OR SALE | |
| OF KRATOM PRODUCT FOR SMOKING. (a) In this section, "smoking" | |
| means burning or igniting a substance and inhaling the smoke or | |
| heating a substance and inhaling the resulting vapor or aerosol. | |
| (b) A person commits an offense if the person manufactures, | |
| distributes, sells, or offers for sale a kratom product or a product | |
| marketed as containing kratom for smoking. | |
| (c) An offense under this section is a Class A misdemeanor. | |
| Sec. 445.0072. OFFENSE: MANUFACTURE, DISTRIBUTION, OR SALE | |
| OF PILL OR TABLET CONTAINING KRATOM. (a) A person commits an | |
| offense if the person manufactures, distributes, sells, or offers | |
| for sale a pill or tablet that contains kratom or that is marketed | |
| as containing kratom. For purposes of this subsection, a capsule is | |
| not considered to be a pill or tablet. | |
| (b) An offense under this section is a Class A misdemeanor. | |
| Sec. 445.008 [ |
|
| violates this chapter is subject to a civil penalty in the amount | |
| of: | |
| (1) $2,500 [ |
|
| (2) $5,000 [ |
|
| (3) $10,000 [ |
|
| (b) Each day a violation continues or occurs is a separate | |
| violation for purposes of imposing a penalty under this section. | |
| (c) [ |
|
| [ |
|
| attorney for the county or municipal attorney for the municipality | |
| in which the violation is alleged to have occurred may bring an | |
| action to recover a civil penalty under this section. | |
| Sec. 445.009 [ |
|
| penalties prescribed by this chapter are in addition to any other | |
| penalties prescribed by law, including penalties prescribed by | |
| Chapters 431 and 481. | |
| Sec. 445.010 [ |
|
| may adopt rules consistent with this chapter as necessary to ensure | |
| the safe consumption and distribution of kratom and kratom | |
| products. | |
| SECTION 2. Section 481.002, Health and Safety Code, is | |
| amended by adding Subdivision (56) to read as follows: | |
| (56) "Kratom" means any part of the leaf of the plant | |
| of the species Mitragyna speciosa. | |
| SECTION 3. Section 481.102, Health and Safety Code, is | |
| amended to read as follows: | |
| Sec. 481.102. PENALTY GROUP 1. Penalty Group 1 consists of: | |
| (1) the following opiates, including their isomers, | |
| esters, ethers, salts, and salts of isomers, esters, and ethers, | |
| unless specifically excepted, if the existence of these isomers, | |
| esters, ethers, and salts is possible within the specific chemical | |
| designation: | |
| Allylprodine; | |
| Alphacetylmethadol; | |
| Benzethidine; | |
| Betaprodine; | |
| Clonitazene; | |
| Diampromide; | |
| Diethylthiambutene; | |
| Difenoxin not listed in Penalty Group 3 or 4; | |
| Dimenoxadol; | |
| Dimethylthiambutene; | |
| Dioxaphetyl butyrate; | |
| Dipipanone; | |
| Ethylmethylthiambutene; | |
| Etodesnitazene; | |
| Etonitazene; | |
| Etoxeridine; | |
| Furethidine; | |
| Hydroxypethidine; | |
| Ketobemidone; | |
| Levophenacylmorphan; | |
| Meprodine; | |
| Methadol; | |
| Moramide; | |
| Morpheridine; | |
| Noracymethadol; | |
| Norlevorphanol; | |
| Normethadone; | |
| Norpipanone; | |
| N-pyrrolidino etonitazene; | |
| Phenadoxone; | |
| Phenampromide; | |
| Phenomorphan; | |
| Phenoperidine; | |
| Piritramide; | |
| Proheptazine; | |
| Properidine; | |
| Propiram; | |
| Protonitazene; | |
| Tilidine; and | |
| Trimeperidine; | |
| (2) the following opium derivatives, their salts, | |
| isomers, and salts of isomers, unless specifically excepted, if the | |
| existence of these salts, isomers, and salts of isomers is possible | |
| within the specific chemical designation: | |
| Acetorphine; | |
| Acetyldihydrocodeine; | |
| Benzylmorphine; | |
| Codeine methylbromide; | |
| Codeine-N-Oxide; | |
| Cyprenorphine; | |
| Desomorphine; | |
| Dihydromorphine; | |
| Drotebanol; | |
| Etorphine, except hydrochloride salt; | |
| Heroin; | |
| Hydromorphinol; | |
| Methyldesorphine; | |
| Methyldihydromorphine; | |
| Monoacetylmorphine; | |
| Morphine methylbromide; | |
| Morphine methylsulfonate; | |
| Morphine-N-Oxide; | |
| Myrophine; | |
| Nicocodeine; | |
| Nicomorphine; | |
| Normorphine; | |
| Pholcodine; and | |
| Thebacon; | |
| (3) the following substances, however produced, | |
| except those narcotic drugs listed in another group: | |
| (A) Opium and opiate not listed in Penalty Group | |
| 3 or 4, and a salt, compound, derivative, or preparation of opium or | |
| opiate, other than thebaine derived butorphanol, nalmefene and its | |
| salts, naloxone and its salts, and naltrexone and its salts, but | |
| including: | |
| Codeine not listed in Penalty Group 3 or 4; | |
| Dihydroetorphine; | |
| Ethylmorphine not listed in Penalty Group 3 | |
| or 4; | |
| Granulated opium; | |
| Hydrocodone not listed in Penalty Group 3; | |
| Hydromorphone; | |
| Metopon; | |
| Morphine not listed in Penalty Group 3; | |
| Opium extracts; | |
| Opium fluid extracts; | |
| Oripavine; | |
| Oxycodone; | |
| Oxymorphone; | |
| Powdered opium; | |
| Raw opium; | |
| Thebaine; and | |
| Tincture of opium; | |
| (B) a salt, compound, isomer, derivative, or | |
| preparation of a substance that is chemically equivalent or | |
| identical to a substance described by Paragraph (A), other than the | |
| isoquinoline alkaloids of opium; | |
| (C) Opium poppy and poppy straw; | |
| (D) Cocaine, including: | |
| (i) its salts, its optical, position, and | |
| geometric isomers, and the salts of those isomers; | |
| (ii) coca leaves and a salt, compound, | |
| derivative, or preparation of coca leaves; and | |
| (iii) a salt, compound, derivative, or | |
| preparation of a salt, compound, or derivative that is chemically | |
| equivalent or identical to a substance described by Subparagraph | |
| (i) or (ii), other than decocainized coca leaves or extractions of | |
| coca leaves that do not contain cocaine or ecgonine; [ |
|
| (E) concentrate of poppy straw, meaning the crude | |
| extract of poppy straw in liquid, solid, or powder form that | |
| contains the phenanthrine alkaloids of the opium poppy; | |
| (F) kratom alkaloids, other than within kratom, | |
| as well as artificial equivalents of the substances naturally | |
| created in a plant of the species Mitragyna speciosa, as well as | |
| synthetic equivalents of the substances naturally created in a | |
| plant of the species Mitragyna speciosa, including: | |
| (i) mitragynine; | |
| (ii) 7-hydroxymitragynine; | |
| (iii) corynantheidine; | |
| (iv) speciofoline; | |
| (v) speciociliatine; | |
| (vi) speciogynine; | |
| (vii) paynantheine; | |
| (viii) mitraciliatine; and | |
| (ix) corynoxine; | |
| (G) any salt, isomer, salt of isomer, compound, | |
| derivative, extract, or preparation of a substance described by | |
| Paragraph (F) with similar pharmacological activity, as well as any | |
| other analogue of a substance described by Paragraph (F) intended | |
| to interact with human opioid receptors; and | |
| (H) Tianeptine and any salt, isomer, salt of | |
| isomer, compound, derivative, extract, or preparation of | |
| tianeptine with similar pharmacological activity, as well as any | |
| other analogue of tianeptine intended to interact with human opioid | |
| receptors; | |
| (4) the following opiates, including their isomers, | |
| esters, ethers, salts, and salts of isomers, if the existence of | |
| these isomers, esters, ethers, and salts is possible within the | |
| specific chemical designation: | |
| Alphaprodine; | |
| Anileridine; | |
| Bezitramide; | |
| Dihydrocodeine not listed in Penalty Group 3 or 4; | |
| Diphenoxylate not listed in Penalty Group 3 or 4; | |
| Isomethadone; | |
| Levomethorphan; | |
| Levorphanol; | |
| Metazocine; | |
| Methadone; | |
| Methadone-Intermediate, 4-cyano-2-dimethylamino- | |
| 4, 4-diphenyl butane; | |
| Moramide-Intermediate, 2-methyl-3-morpholino-1, | |
| 1-diphenyl-propane-carboxylic acid; | |
| PEPAP (1-(2-phenethyl)-4-phenyl-4- | |
| acetoxypiperidine); | |
| Pethidine (Meperidine); | |
| Pethidine-Intermediate-A, 4-cyano-1-methyl-4- | |
| phenylpiperidine; | |
| Pethidine-Intermediate-B, ethyl-4- | |
| phenylpiperidine-4 carboxylate; | |
| Pethidine-Intermediate-C, 1-methyl-4- | |
| phenylpiperidine-4-carboxylic acid; | |
| Phenazocine; | |
| Piminodine; | |
| Racemethorphan; and | |
| Racemorphan; | |
| (5) Flunitrazepam (trade or other name: Rohypnol); | |
| (6) Methamphetamine, including its salts, optical | |
| isomers, and salts of optical isomers; | |
| (7) Phenylacetone and methylamine, if possessed | |
| together with intent to manufacture methamphetamine; | |
| (8) Phencyclidine, including its salts; | |
| (9) Gamma hydroxybutyric acid (some trade or other | |
| names: gamma hydroxybutyrate, GHB), including its salts; | |
| (10) Ketamine; | |
| (11) Phenazepam; | |
| (12) U-47700; | |
| (13) AH-7921; | |
| (14) ADB-FUBINACA; | |
| (15) AMB-FUBINACA; and | |
| (16) MDMB-CHMICA. | |
| SECTION 4. Section 481.103(a), Health and Safety Code, is | |
| amended to read as follows: | |
| (a) Penalty Group 2 consists of: | |
| (1) any quantity of the following hallucinogenic | |
| substances, their salts, isomers, and salts of isomers, unless | |
| specifically excepted, if the existence of these salts, isomers, | |
| and salts of isomers is possible within the specific chemical | |
| designation: | |
| 5-(2-aminopropyl)benzofuran (5-APB); | |
| 6-(2-aminopropyl)benzofuran (6-APB); | |
| 5-(2-aminopropyl)-2,3-dihydrobenzofuran | |
| (5-APDB); | |
| 6-(2-aminopropyl)-2,3-dihydrobenzofuran | |
| (6-APDB); | |
| 5-(2-aminopropyl)indole (5-IT,5-API); | |
| 6-(2-aminopropyl)indole (6-IT,6-API); | |
| 1-(benzofuran-5-yl)-N-methylpropan-2-amine | |
| (5-MAPB); | |
| 1-(benzofuran-6-yl)-N-methylpropan-2-amine | |
| (6-MAPB); | |
| Benzothiophenylcyclohexylpiperidine (BTCP); | |
| 8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran- | |
| 4-ethanamine (trade or other name: Bromo-DragonFLY); | |
| Desoxypipradrol (2-benzhydrylpiperidine); | |
| 2, 5-dimethoxyamphetamine (some trade or other | |
| names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); | |
| Diphenylprolinol (diphenyl(pyrrolidin-2-yl) | |
| methanol, D2PM); | |
| Dronabinol (synthetic) in sesame oil and | |
| encapsulated in a soft gelatin capsule in a U.S. Food and Drug | |
| Administration approved drug product (some trade or other names for | |
| Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- | |
| trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- | |
| (trans)- tetrahydrocannabinol); | |
| Ethylamine Analog of Phencyclidine (some trade or | |
| other names: N-ethyl-1-phenylcyclohexylamine, (1- | |
| phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, | |
| cyclohexamine, PCE); | |
| 2-ethylamino-2-(3-methoxyphenyl)cyclohexanone | |
| (trade or other name: methoxetamine); | |
| Ibogaine (some trade or other names: 7-Ethyl-6, | |
| 6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- | |
| pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); | |
| 5-iodo-2-aminoindane (5-IAI); | |
| Mescaline; | |
| 5-methoxy-3, 4-methylenedioxy amphetamine; | |
| 4-methoxyamphetamine (some trade or other | |
| names: 4-methoxy-alpha-methylphenethylamine; | |
| paramethoxyamphetamine; PMA); | |
| 4-methoxymethamphetamine (PMMA); | |
| 2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone | |
| (some trade and other names: 2-MeO-ketamine; methoxyketamine); | |
| 1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, | |
| PPMP); | |
| 4-methyl-2, 5-dimethoxyamphetamine (some trade | |
| and other names: 4-methyl-2, 5-dimethoxy-alpha- | |
| methylphenethylamine; "DOM"; "STP"); | |
| 3,4-methylenedioxy methamphetamine (MDMA, MDM); | |
| 3,4-methylenedioxy amphetamine; | |
| 3,4-methylenedioxy N-ethylamphetamine (Also | |
| known as N-ethyl MDA); | |
| 5,6-methylenedioxy-2-aminoindane (MDAI); | |
| Nabilone (Another name for nabilone: (+)-trans- | |
| 3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, | |
| 6-dimethyl-9H-dibenzo[b,d] pyran-9-one; | |
| N-benzylpiperazine (some trade or other | |
| names: BZP; 1-benzylpiperazine); | |
| N-ethyl-3-piperidyl benzilate; | |
| N-hydroxy-3,4-methylenedioxyamphetamine (Also | |
| known as N-hydroxy MDA); | |
| 4-methylaminorex; | |
| N-methyl-3-piperidyl benzilate; | |
| Parahexyl (some trade or other names: 3-Hexyl-1- | |
| hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] | |
| pyran; Synhexyl); | |
| 1-Phenylcyclohexylamine; | |
| 1-Piperidinocyclohexanecarbonitrile (PCC); | |
| Pyrrolidine Analog of Phencyclidine (some trade | |
| or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); | |
| Tetrahydrocannabinols, other than marihuana, and | |
| synthetic equivalents of the substances contained in the plant, or | |
| in the resinous extractives of Cannabis, or synthetic substances, | |
| derivatives, and their metabolites, isomers, acids, salts, and | |
| salts of isomers with similar chemical structure and | |
| pharmacological activity, including [ |
|
| delta-1 cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-6 cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-3, 4 cis or trans | |
| tetrahydrocannabinol, and its optical isomers; | |
| delta-5, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-6a, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-7, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-7a, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-8, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-10, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-10a, cis or trans | |
| tetrahydrocannabinol, and their optical isomers; | |
| delta-11, cis or trans tetrahydrocannabinol, | |
| and their optical isomers; | |
| delta-11-Hydroxy-tetrahydrocannabinol; | |
| exo-tetrahydrocannabinol; | |
| tetrahydrocannabivarins, including delta-8 | |
| tetrahydrocannabivarin; | |
| 11-hydroxy-tetrahydrocannabinol; | |
| 3-hydroxy-tetrahydrocannabinol; | |
| 7-hydroxy-tetrahydrocannabinol; | |
| hexahydrocannabiphorol-o-ester; | |
| hydrogenated forms of tetrahydrocannabinol, | |
| including hexahydrocannabinol, hexahydrocannabiphorol, and | |
| hexahydrocannabihexol; | |
| hydrogenated forms of hexahydrocannabinol, | |
| including 8-hydroxyhexahydrocannabinol and | |
| 10-hydroxyhexahydrocannabinol; | |
| ester forms of tetrahydrocannabinol, | |
| including delta-8 THC-O-acetate, delta-9 THC-O-acetate, and | |
| hexahydrocannabinol-O-acetate; | |
| tetrahydrocannabinols with alkyl chain of | |
| four or more carbon atoms, including tetrahydrocannabiphorols, | |
| tetrahydrocannabioctyls, tetrahydrocannabihexols, | |
| tetrahydrocannabidiol, and tetrahydrocannabutols; | |
| tetrahydrocannabinol acetate; | |
| tetrahydrocannabinol methyl ester; or | |
| compounds of these structures, regardless of | |
| numerical designation of atomic positions, since nomenclature of | |
| these substances is not internationally standardized; | |
| Thiophene Analog of Phencyclidine (some trade or | |
| other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl | |
| Analog of Phencyclidine; TPCP, TCP); | |
| 1-pyrrolidine (some trade or other name: TCPy); | |
| 1-(3-trifluoromethylphenyl)piperazine (trade or | |
| other name: TFMPP); and | |
| 3,4,5-trimethoxy amphetamine; | |
| (2) Phenylacetone (some trade or other | |
| names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl | |
| ketone); | |
| (3) unless specifically excepted or unless listed in | |
| another Penalty Group, a material, compound, mixture, or | |
| preparation that contains any quantity of the following substances | |
| having a potential for abuse associated with a depressant or | |
| stimulant effect on the central nervous system: | |
| Aminorex (some trade or other | |
| names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- | |
| phenyl-2-oxazolamine); | |
| Amphetamine, its salts, optical isomers, and | |
| salts of optical isomers; | |
| Cathinone (some trade or other names: 2-amino-1- | |
| phenyl-1-propanone, alpha-aminopropiophenone, 2- | |
| aminopropiophenone); | |
| Etaqualone and its salts; | |
| Etorphine Hydrochloride; | |
| Fenethylline and its salts; | |
| Lisdexamfetamine, including its salts, isomers, | |
| and salts of isomers; | |
| Mecloqualone and its salts; | |
| Methaqualone and its salts; | |
| Methcathinone (some trade or other names: 2- | |
| methylamino-propiophenone; alpha-(methylamino)propriophenone; | |
| 2-(methylamino)-1-phenylpropan-1-one; alpha-N- | |
| methylaminopropriophenone; monomethylpropion; ephedrone, N- | |
| methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR | |
| 1431); | |
| N-Ethylamphetamine, its salts, optical isomers, | |
| and salts of optical isomers; and | |
| N,N-dimethylamphetamine (some trade or other | |
| names: N,N,alpha-trimethylbenzeneethanamine; | |
| N,N,alpha-trimethylphenethylamine), its salts, optical isomers, | |
| and salts of optical isomers; | |
| (4) any compound structurally derived from | |
| 2-aminopropanal by substitution at the 1-position with any | |
| monocyclic or fused-polycyclic ring system, including: | |
| (A) compounds further modified by: | |
| (i) substitution in the ring system to any | |
| extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or | |
| halide substituents), whether or not further substituted in the | |
| ring system by other substituents; | |
| (ii) substitution at the 3-position with an | |
| alkyl substituent; or | |
| (iii) substitution at the 2-amino nitrogen | |
| atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or | |
| inclusion of the 2-amino nitrogen atom in a cyclic structure; and | |
| (B) by example, compounds such as: | |
| 4-Methylmethcathinone (Also known as | |
| Mephedrone); | |
| 3,4-Dimethylmethcathinone (Also known as | |
| 3,4-DMMC); | |
| 3-Fluoromethcathinone (Also known as 3-FMC); | |
| 4-Fluoromethcathinone (Also known as | |
| Flephedrone); | |
| 3,4-Methylenedioxy-N-methylcathinone (Also | |
| known as Methylone); | |
| 3,4-Methylenedioxypyrovalerone (Also known | |
| as MDPV); | |
| alpha-Pyrrolidinopentiophenone (Also known | |
| as alpha-PVP); | |
| Naphthylpyrovalerone (Also known as | |
| Naphyrone); | |
| alpha-Methylamino-valerophenone (Also known | |
| as Pentedrone); | |
| beta-Keto-N-methylbenzodioxolylpropylamine | |
| (Also known as Butylone); | |
| beta-Keto-N-methylbenzodioxolylpentanamine | |
| (Also known as Pentylone); | |
| beta-Keto-Ethylbenzodioxolylbutanamine | |
| (Also known as Eutylone); and | |
| 3,4-methylenedioxy-N-ethylcathinone (Also | |
| known as Ethylone); | |
| (5) any compound structurally derived from tryptamine | |
| (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine: | |
| (A) by modification in any of the following ways: | |
| (i) by substitution at the amine nitrogen | |
| atom of the sidechain to any extent with alkyl or alkenyl groups or | |
| by inclusion of the amine nitrogen atom of the side chain (and no | |
| other atoms of the side chain) in a cyclic structure; | |
| (ii) by substitution at the carbon atom | |
| adjacent to the nitrogen atom of the side chain (alpha-position) | |
| with an alkyl or alkenyl group; | |
| (iii) by substitution in the 6-membered | |
| ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl, | |
| alkylenedioxy, or halide substituents; or | |
| (iv) by substitution at the 2-position of | |
| the tryptamine ring system with an alkyl substituent; and | |
| (B) including: | |
| (i) ethers and esters of the controlled | |
| substances listed in this subdivision; and | |
| (ii) by example, compounds such as: | |
| alpha-ethyltryptamine; | |
| alpha-methyltryptamine; | |
| Bufotenine (some trade and other names: | |
| 3-(beta-Dimethylaminoethyl)-5-hydroxyindole; | |
| 3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin; | |
| 5-hydroxy-N, N- dimethyltryptamine; mappine); | |
| Diethyltryptamine (some trade and | |
| other names: N, N-Diethyltryptamine, DET); | |
| Dimethyltryptamine (trade or other | |
| name: DMT); | |
| 5-methoxy-N, N-diisopropyltryptamine | |
| (5-MeO-DiPT); | |
| O-Acetylpsilocin (Trade or other name: | |
| 4-Aco-DMT); | |
| Psilocin; and | |
| Psilocybin; | |
| (6) 2,5-Dimethoxyphenethylamine and any compound | |
| structurally derived from 2,5-Dimethoxyphenethylamine by | |
| substitution at the 4-position of the phenyl ring to any extent | |
| (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide | |
| substituents), including, by example, compounds such as: | |
| 4-Bromo-2,5-dimethoxyphenethylamine (trade or | |
| other name: 2C-B); | |
| 4-Chloro-2,5-dimethoxyphenethylamine (trade or | |
| other name: 2C-C); | |
| 2,5-Dimethoxy-4-methylphenethylamine (trade or | |
| other name: 2C-D); | |
| 4-Ethyl-2,5-dimethoxyphenethylamine (trade or | |
| other name: 2C-E); | |
| 4-Iodo-2,5-dimethoxyphenethylamine (trade or | |
| other name: 2C-I); | |
| 2,5-Dimethoxy-4-nitrophenethylamine (trade or | |
| other name: 2C-N); | |
| 2,5-Dimethoxy-4-(n)-propylphenethylamine (trade | |
| or other name: 2C-P); | |
| 4-Ethylthio-2,5-dimethoxyphenethylamine (trade | |
| or other name: 2C-T-2); | |
| 4-Isopropylthio-2,5-dimethoxyphenethylamine | |
| (trade or other name: 2C-T-4); and | |
| 2,5-Dimethoxy-4-(n)-propylthiophenethylamine | |
| (trade or other name: 2C-T-7); [ |
|
| (7) 2,5-Dimethoxyamphetamine and any compound | |
| structurally derived from 2,5-Dimethoxyamphetamine by substitution | |
| at the 4-position of the phenyl ring to any extent (including alkyl, | |
| alkoxy, alkylenedioxy, haloalkyl, or halide substituents), | |
| including, by example, compounds such as: | |
| 4-Ethylthio-2,5-dimethoxyamphetamine (trade or | |
| other name: Aleph-2); | |
| 4-Isopropylthio-2,5-dimethoxyamphetamine (trade | |
| or other name: Aleph-4); | |
| 4-Bromo-2,5-dimethoxyamphetamine (trade or other | |
| name: DOB); | |
| 4-Chloro-2,5-dimethoxyamphetamine (trade or | |
| other name: DOC); | |
| 2,5-Dimethoxy-4-ethylamphetamine (trade or other | |
| name: DOET); | |
| 4-Iodo-2,5-dimethoxyamphetamine (trade or other | |
| name: DOI); | |
| 2,5-Dimethoxy-4-methylamphetamine (trade or | |
| other name: DOM); | |
| 2,5-Dimethoxy-4-nitroamphetamine (trade or other | |
| name: DON); | |
| 4-Isopropyl-2,5-dimethoxyamphetamine (trade or | |
| other name: DOIP); and | |
| 2,5-Dimethoxy-4-(n)-propylamphetamine (trade or | |
| other name: DOPR); and | |
| (8) any quantity of the following hallucinogenic | |
| substances, their salts, isomers, salts of isomers, ethers, and | |
| esters unless specifically excepted, if the existence of these | |
| salts, isomers, salts of isomers, ethers, and esters is possible: | |
| Ibotenic acid; and | |
| Muscimol. | |
| SECTION 5. The changes in law made by this Act apply only to | |
| an offense committed on or after the effective date of this Act. An | |
| offense committed before the effective date of this Act is governed | |
| by the law in effect on the date the offense was committed, and the | |
| former law is continued in effect for that purpose. For purposes of | |
| this section, an offense was committed before the effective date of | |
| this Act if any element of the offense occurred before that date. | |
| SECTION 6. To the extent of any conflict, this Act prevails | |
| over another Act of the 89th Legislature, Regular Session, 2025, | |
| relating to nonsubstantive additions to and corrections in enacted | |
| codes. | |
| SECTION 7. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.